- The modifier subunit of glutamate cysteine ligase (GCLM) is a molecular target for amelioration of cisplatin resistance in lung cancer. Inoue, Y., Tomisawa, M., Yamazaki, H., Abe, Y., Suemizu, H., Tsukamoto, H., Tomii, Y., Kawamura, M., Kijima, H., Hatanaka, H., Ueyama, Y., Nakamura, M., Kobayashi, K. Int. J. Oncol. (2003)